» Articles » PMID: 30360780

Endothelial Extracellular Vesicles in Pulmonary Function and Disease

Overview
Journal Curr Top Membr
Date 2018 Oct 27
PMID 30360780
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

The pulmonary vascular endothelium is involved in the pathogenesis of acute and chronic lung diseases. Endothelial cell (EC)-derived products such as extracellular vesicles (EVs) serve as EC messengers that mediate inflammatory as well as cytoprotective effects. EC-EVs are a broad term, which encompasses exosomes and microvesicles of endothelial origin. EVs are comprised of lipids, nucleic acids, and proteins that reflect not only the cellular origin but also the stimulus that triggered their biogenesis and secretion. This chapter presents an overview of the biology of EC-EVs and summarizes key findings regarding their characteristics, components, and functions. The role of EC-EVs is specifically delineated in pulmonary diseases characterized by endothelial dysfunction, including pulmonary hypertension, acute respiratory distress syndrome and associated conditions, chronic obstructive pulmonary disease, and obstructive sleep apnea.

Citing Articles

Endothelial extracellular vesicles: their possible function and clinical significance in diabetic vascular complications.

Fang X, Zhang Y, Zhang Y, Guan H, Huang X, Miao R J Transl Med. 2024; 22(1):944.

PMID: 39415278 PMC: 11481601. DOI: 10.1186/s12967-024-05760-0.


Laboratory Tools to Predict CFTR Modulator Therapy Effectiveness and to Monitor Disease Severity in Cystic Fibrosis.

Bacalhau M, Camargo M, Lopes-Pacheco M J Pers Med. 2024; 14(1).

PMID: 38248793 PMC: 10820563. DOI: 10.3390/jpm14010093.


Extracellular vesicles in acute respiratory distress syndrome: Understanding protective and harmful signaling for the development of new therapeutics.

Bavuso M, Miller N, Sill J, Dobrian A, Colunga Biancatelli R Histol Histopathol. 2023; 39(2):131-144.

PMID: 37712224 DOI: 10.14670/HH-18-659.


Extracellular vesicles: pathogenic messengers and potential therapy for neonatal lung diseases.

Wu S, Benny M, Duara J, Williams K, Tan A, Schmidt A Front Pediatr. 2023; 11:1205882.

PMID: 37397144 PMC: 10311919. DOI: 10.3389/fped.2023.1205882.


Extracellular Vesicles' Role in the Pathophysiology and as Biomarkers in Cystic Fibrosis and COPD.

Di Gioia S, Daniello V, Conese M Int J Mol Sci. 2023; 24(1).

PMID: 36613669 PMC: 9820204. DOI: 10.3390/ijms24010228.


References
1.
Combes V, Simon A, Grau G, Arnoux D, Camoin L, Sabatier F . In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest. 1999; 104(1):93-102. PMC: 408397. DOI: 10.1172/JCI4985. View

2.
Cool C, Stewart J, Werahera P, Miller G, Williams R, Voelkel N . Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers. Evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth. Am J Pathol. 1999; 155(2):411-9. PMC: 1866857. DOI: 10.1016/S0002-9440(10)65137-1. View

3.
Blann A, Lip G . Virchow's triad revisited: the importance of soluble coagulation factors, the endothelium, and platelets. Thromb Res. 2001; 101(4):321-7. DOI: 10.1016/s0049-3848(00)00419-9. View

4.
Mitani Y, Ueda M, Komatsu R, Maruyama K, Nagai R, Matsumura M . Vascular smooth muscle cell phenotypes in primary pulmonary hypertension. Eur Respir J. 2001; 17(2):316-20. DOI: 10.1183/09031936.01.17203160. View

5.
Joop K, Berckmans R, Nieuwland R, Berkhout J, Romijn F, Hack C . Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms. Thromb Haemost. 2001; 85(5):810-20. View